Literature DB >> 18521524

PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a meta-analysis of 19 studies comprising 3,003 patients.

Marilena Crescente, Augusto Di Castelnuovo, Licia Iacoviello, Giovanni de Gaetano, Chiara Cerletti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18521524     DOI： 10.1160/TH08-03-0130

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  9 in total

1.  Effect of chronic kidney disease on platelet reactivity to dual-antiplatelet therapy in patients treated with drug-eluting stents.

Authors:  Takahide Arai; Akio Kawamura; Yumiko Matsubara; Kenji Yokoyama; Yasuo Ikeda; Keiichi Fukuda; Mitsuru Murata
Journal:  Heart Vessels       Date:  2011-08-12       Impact factor: 2.037

2.  Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes.

Authors:  Faouzi Addad; Tahar Chakroun; Ismail Elalamy; Fatma Abderazek; Saoussen Chouchene; Zohra Dridi; Gregoris T Gerotziafas; Mohamed Hatmi; Mohsen Hassine; Habib Gamra
Journal:  Int J Hematol       Date:  2010-08-20       Impact factor: 2.490

3.  Selecting optimal antiplatelet therapy based on platelet function monitoring in patients with coronary artery disease.

Authors:  Paul A Gurbel; Udaya S Tantry
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-02

4.  Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery.

Authors:  Tyler J Gluckman; Rhondalyn C McLean; Steven P Schulman; Thomas S Kickler; Edward P Shapiro; John V Conte; Kathleen W McNicholas; Jodi B Segal; Jeffrey J Rade
Journal:  J Am Coll Cardiol       Date:  2011-03-01       Impact factor: 24.094

5.  Clinical importance of aspirin and clopidogrel resistance.

Authors:  Gergely Feher; Andrea Feher; Gabriella Pusch; Katalin Koltai; Antal Tibold; Beata Gasztonyi; Elod Papp; Laszlo Szapary; Gabor Kesmarky; Kalman Toth
Journal:  World J Cardiol       Date:  2010-07-26

Review 6.  Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events.

Authors:  Joonseok Kim; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

7.  Clinical and laboratory factors associated with shear-dependent platelet hyper-reactivity in patients on chronic aspirin therapy.

Authors:  Susanna M Nazarian; Jason B Thompson; Tyler J Gluckman; Katherine Laws; Jayesh T Jani; Thomas S Kickler; Jeffrey J Rade
Journal:  Thromb Res       Date:  2009-06-05       Impact factor: 3.944

8.  Von Willebrand factor antigen predicts response to double dose of aspirin and clopidogrel by PFA-100 in patients undergoing primary angioplasty for ST elevation myocardial infarction.

Authors:  Jacopo Gianetti; Maria Serena Parri; Francesca Della Pina; Federica Marchi; Endrin Koni; Alberto De Caterina; Stefano Maffei; Sergio Berti
Journal:  ScientificWorldJournal       Date:  2013-12-19

Review 9.  Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond).

Authors:  Marilena Crescente; Laura Menke; Melissa V Chan; Paul C Armstrong; Timothy D Warner
Journal:  Br J Pharmacol       Date:  2018-04-19       Impact factor: 8.739
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.